VIMKUNYA
NDC 50632-018, Chikungunya Vaccine, Recombinant, injection, suspension, from Bavarian Nordic A/S.
- Product NDC
- 50632-018
- Status
- Listed
- Labeler
- Bavarian Nordic A/S
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125820
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50632-018 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 CAPSID PROTEIN10 ug/.8mL
- CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 ENVELOPE PROTEIN E115 ug/.8mL
- CHIKUNGUNYA VIRUS SENEGAL STRAIN 37997 ENVELOPE PROTEIN E215 ug/.8mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50632-018-02 | 50632001802 | 1 SYRINGE, GLASS in 1 CARTON (50632-018-02) / .8 mL in 1 SYRINGE, GLASS (50632-018-04) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50632-018 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50632-018 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50632-018. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.